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SUMMARY 
• Sex hormones have developmental trophic actions on 
neurons and glial cells and activational effects in the adult 
brain. It has been proposed that sex steroids may interact with 
peptide trophic factors to induce part of their biological effects 
in the nervous system. The first evidence of such an interaction 
was provided by Toran-Allerand et al (Brain Res 1980; 184: 
517-524), showing that in explant cultures of fetal rodent hy- 
polhalamus, estrogen and insulin have synergistic effects on 
nei/rite growth, an effect probably mediated by insulin-like 
growth factor-1 receptors. Recent data indicate that estrogen 
and insulin-like growth factor-! signaling pathways interact 
on hypothalamic neurons to regulate survival and differentia- 
tion and that sex steroids interact with a variety of different 
trophic signals in vivo to regulate neuroendocrine events. 
These findings suggest that trophic factors may be involved in 
the genesis of sex differences in the developing brain and in the 
maintenance of a sexually differentiated brain function in the 
adult. (BioinedRev 1997; 7: 67-74) 
INTRODUCTION 
• Hormonal steroids modulate behavior, brain physiology 
and neuroendocrine function by exerting a variety of different 
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effects on specific neuronal populations. The mechanism of 
action of hormonal steroids in the nervous system, as in other 
tissues, involves the activation of specific nuclear receptors that 
act as transcription factors for specific genes (1,2). In addition, 
steroid hormones may modulate neuronal excitability by hav- 
ing rapid non-genomic actions (3). Neural activity is also modu- 
lated by sex steroid metabolites produced by nerve cells and by 
local steroids that are synthesized de novo in the brain from 
cholesterol (4). In this review we examine evidence generated in 
studies on rodents indicating that sex steroids may act as trophic 
factors for neural cells and as promoters of neural differentia- 
tion and plasticity. This trophic and plastic effect of sex steroids 
may be mediated in part by interaction with other trophic mol- 
ecules of peptide nature. In particular, complex interactions of 
one such molecule, insulin-like growth factor-I (IGF-I), and es- 
tradiol have been documented recently in hypothalamic neu- 
rons. 
SEX HORMONES AND CELL 
COMMUNICATION IN BRAIN 
• Due to the complex pattern of cell interactions in the 
development of the central nervous system (CNS), it is difficult 
to determine whether the effect of sex steroids on a given neu- 
ral cell type is directly exerted on that cell or mediated by other 
neurons or glial cells. Since many neurons express receptors 
for gonadal steroids and since gonadal hormones and their me- 
tabolites may have a variety of direct rapid effects on neuronal 
membranes, it is presumable that steroids will directly affect 
many different neurons throughout the brain. However, indi- 
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reel effects are probably very important as well. Acting on their 
target neurons, for example, gonadal hormones may induce the 
release of neurotransmitters and trophic factors that could af- 
fect the development and function of other neurons. Further- 
more, by promoting neuronal survival and differentiation of their 
target cells, gonadal hormones could also affect the survival and 
differentiation of the neurons that contact these cells. 
The action of sex hormones in the brain involves not only neu- 
ron-to-neuron communication since glial cells are also affected 
by sex hormones and their metabolites (5). Glial cells are a 
source of growth factors for neurons, promoting neuronal sur- 
vival and differentiation. Several laboratories have shown that 
glial cells in culture express receptors for sex steroids (6, 7), 
suggesting that at least in early stages of brain development 
glial cells may be a direct target of these hormones (6, 7). Fur- 
thermore, it has been reported that hypothalamic glia in situ 
expresses estrogen receptors, based on immunohistochemical 
evidence (8). Sex hormones and neurosteroids affect myelination 
by acting on oligodendrocytes and Schwann cells (9,10) and 
modulate the response of nerve tissue to injury by acting on 
microglia and astroglia (5, 1 1). In addition to being a target for 
sex steroids, glial cells are also involved in their metabolism (12) 
and in the synthesis of neurosteroids (10, 13-15) and participate 
in the organizational and activational effects of sex steroids on 
synapse formation (16, 17) and synaptic plasticity (18,19). 
GONADAL HORMONES ACT AS 
NEUROTROPHIC FACTORS 
• It is classically recognized that sex steroids exert organi- 
zational effects during the critical period for brain sexual differ- 
entiation and activational effects in the adult brain (20). During 
the CNS development, gonadal steroids determine the number 
of neurons in several brain areas. One of the best studied ex- 
amples is the sexually dimorphic nucleus of the preoptic area in 
rodents, which is larger in volume in males than in females (21, 
22). This difference in nuclear size is at least partially due to the 
action of gonadal steroids during the critical period, promoting 
the survival of a specific population of neurons (23). Another 
example of a sexually dimorphic structure in the CNS of rodents 
is the spinal nucleus of the bulbocavernosus (24). Androgens 
prevent normal cell death of moloneurons of this nucleus (25). 
These studies suggest that sex steroids may act as neurotrophic 
factors, promoting the survival of specific neurons or regulat- 
ing apoptosis (26). 
Neurotrophic effects of sex steroids have been characterized in 
vitro. Estradiol promotes the survival of cultured neurons from 
the amygdala, the hypothalamus and the spinal cord (26a-29). 
The effect of estradiol on the survival of cultured hypothalamic 
neurons is mimicked by testosterone, bu t  not by the non- 
aromatizable androgen dihydrotestosterone (28). The effect 
appears to be mediated in part through the estrogen receptor 
since it is saturable and can be blocked by estrogen receptor 
antagonists, such as tamoxifen and ICI 182,780, and by the 
inhibition of estrogen receptor synthesis in the cultures by us- 
ing an antisense oligonucleotide against estrogen receptor 
mRNA (28, 29). 
In addition to the effects on cell number, sex steroids also affect 
neuronal differentiation in several brain areas, modulating the 
growth of axons, the number and branching of dendrites and 
the number of dendritic spines. Estradiol modulates, for in- 
stance, the growth of neurites in hypothalamic neurons in ex- 
plant cultures (30,31) and monolayer cultures (29,32, 33), while 
in the spinal nucleus of the bulbocavernosus, androgens regu- 
late dendritic outgrowth during the neonatal period and den- 
dritic retraction during the pubertal period (34, 35). Gonadal ste- 
roid-dependent sex differences in neuronal processes have been 
detected in other brain structures, including the preoptic area 
(36) and hippocampus (37). These effects of gonadal hormones 
on the differentiation of neuronal processes are mediated, at least 
in part, by the modulation of cytoskeletal proteins (29, 32, 38). 
Hormonal modifications in the growth of neuronal processes 
may result in changes in the pattern of neuronal connectivity. 
It is well established that during the critical period gonadal 
steroids influence the formation of synaptic contacts among 
neurons, resulting in specific sex differences in neuronal con- 
nectivity. Furthermore, the effect of sexrhormoncs on synapses 
is not restricted to the developmental period. Synapses are plas- 
tic structures that may be modified in the adult brain in response 
to changing physiological conditions, including modifications 
in hormone levels (18, 39). Gonadal hormones influence syn- 
apse formation in areas of the CNS involved in the control of 
reproductive behavior, such as the ventromedial hypothalamic 
nucleus, lateral septum and the amygdala and in areas involved 
in the control of the release of pituitary hormones, such as the 
hypothalamic arcuate nucleus and the preoptic area. In addi- 
tion, gonadal hormones may affect neuronal connectivity in 
cognitive areas, such as the hippocampal formation and the 
cerebral cortex (18,37, 39-41). 
INTERACTION OF SEX STEROIDS AND 
TROPHIC FACTORS 
• The complexity of gonadal steroid action on the brain is 
not only a consequence of the complexity of cellular interac- 
tions in the neural tissue. Interactions between the signaling 
cascades of membrane receptors for peptidic factors and the 
steroid hormone receptors should also be taken into consider- 
ation. One of the best characterized neurotrophic factors, and 
the first one discovered, is nerve growth factor (NGF). In some 
brain areas and during specific developmental stages estradiol 
and NGF may affect the same target neurons. Genes encoding   
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NGP and the low-affinity receptor for NGP (p75) are expressed 
in subpopulations of neurons of hypothalamic neuroendocrine 
areas (42). Furthermore, it has been shown thatestrogen recep- 
tors colocalize with p75 in cholinergic neurons of the basal fore- 
brain of developing rodents (43). Estradiol may therefore exert 
part of its trophic effects modulating the action of NGF. This is 
further supported by the fact that estradiol is able to modulate 
the levels of NGF receptors in PC 12 cells, in cerebral cortical 
cultures and in dorsal root ganglion neurons of adult female rats 
(44-46). Moreover, putative estrogen responsive elements have 
been identified in the NGP gene and in the genes for the NGF 
tyrosinc kinase (trkA) and low-affinity receptors (46). By regu- 
lating trkA or p75 levels, estradiol may affect programmed neu- 
mnaldcath (26,47). 
A putative estrogen receptor element has been identified also 
in the gene encoding brain-derived neurotrophic factor (4 8). The 
receptor trkB for this ncurotrophin is expressed in neurons from 
hypothalamic neuroendocrine areas, as well as trkC, which is 
thercceptorforneurotrophin-3(42). 
In addition to neurotrophins, other trophic factors may also be 
relevant in regard to the action of sex steroids in the brain. 
These include basic fibroblast growth factor (bPGF) and trans- 
forming growth factors-ex (TGF-a) and -p (TGF-p), which appear 
to he involved in the maturation of the neuroendocrine hypo- 
thalamus and/or in the regulation of luteinizing hormone-releas- 
ing hormone (LHRH) neurons (49-52). Sex steroids may interact 
with some of these factors to exert their effects on neurons and 
glial cells. Also, estrogen modulates the expression of TGF-(% in 
(he hypothalamus (50). This factor is produced by hypothalamic 
glial cells and appears to regulate LHRH neurons (49, 50, 53). 
Gene expression of TGF-(% increases in glial cells at the time of 
puberty in regions of the hypothalamus involved in LHRH con- 
troll (50). 
Another factor that may be involved in the effects of gonadal 
hormones on brain is IGF-I. This factor is highly expressed by 
glia and neurons of the developing brain (54,55) and has promi- 
nent trophic actions, stimulating the survival and differentia- 
tion of specific neural cell populations, including hypothalamic 
neurons in culture (28. 56). IGF-1 may also act as a hormonal 
signal and may be involved in the feed-back regulation of 
growth hormone by affecting the synthesis or release of growth 
hormone-releasing hormone or somatostatin by hypothalamic 
neurons (57,58). IGF-1 may also affect the reproductive axis by 
mo(.lulatingthcsecretionol'LHRH(59-6l). .. 
INTERACTION OF ESTRADIOL AND INSULIN- 
LIKE GROWTH FACTOR'1  
 In several tissues and cell types estrogen uprcgulates 
1GP-1 gene expression (62-68) and modulates IGF-1 action by 
affecting the levels of IGP-I receptors (63, 69) and IGF-bind- 
ing proteins (70,73) which appear to modulate the availability 
of IGF-I to target cells. Likewise, IGF-I may regulate steroid hor- 
mone action by stimulating the synthesis of steroid hormones 
(74-76) and steroid hormone receptors (77-79). Furthermore, 
IGF-I, as other growth factors, may activate the estrogen recep- 
tor in different cell lines, including neuroblastoma cells (80-85). 
This activation of the estrogen receptor occurs in the absence 
of the hormone. It is mediated by IGF-I receptor membrane- 
associated signaling pathways (82,85) and involves the activa- 
tion function 2 domain of the estrogen receptor in neuroblas- 
toma cells (85) and the activation function 1 domain in other cell 
lines (81,82). 
The first evidence of an interaction between IGP-I and estrogen 
on neural cells was obtained in explant cultures of fetal rodent 
hypothalamus where estrogen and insulin have synergistic ef- 
fects on neurite growth, an effect that is probably mediated 
through IGP-I receptors (86). Furthermore, estrogen modulates 
IGF-I receptors and binding proteins in monolayer hypothalamic 
cultures (87) and estrogen effects on hypothalamic neuronal sur- 
vival and neurite growth are mediated by IGF-I (29). Hypotha- 
lamic cultures exposed to estradiol or IGF-I show a significant 
increase in neuronal survival and in the growth of neuronal pro- 
cesses. Inhibition of IGP-I synthesis in the cultures with an 
antisensc oligonucleotide to mRNA'̂ "' results in a significant 
decrease in the stimulatory effects of 17B-estradiol on the num- 
ber of neurons and the extension of neuronal processes (29). 
This indicates that IGF-I is necessary for the manifestation of 
the hormonal effect, suggesting that estradiol may induce neu- 
ronal survival and differentiation by activation ofIGF-I signal- 
ing cascades. Also, the effect of IGF-I on the survival and dif- 
ferentiation of hypothalamic neurons depends on the estrogen 
receptor (29). Both the pure estrogen receptor antagonist ICI 
182,780 or an antisense oligode-oxynucleotide to the estrogen 
receptor mRNA block the effects of IGF-I. This indicates that 
estrogen receptors are necessary for the action of IGF-I on hy- 
pothalamic survival and neuritic growth, suggesting that IGP-I 
may activate, either directly or indirectly, estrogen receptors. 
Interactions of sex steroids and IGF-I are also detected in the 
brain m j;Y«. IGF-I levels increase in the arcuate nucleus and 
median eminence of male and female rats at the time of pu- 
berty, with males reaching higher levels than females (88). This 
sex difference is abolished by perinatal administration of tes- 
tosterone to females. Furthermore, in females there is an abrupt 
increase in IGF-I levels between the morning and the afternoon 
of the first proestrus. Henceforth, IGP-I levels fluctuate in the 
arcuate nucleus and median eminence according to the differ- 
ent stages of the estrus cycle. IGF-I levels are high in the after- 
noon of proestrus, after the peak of estrogen in plasma, remain 
increased on the morning of the following day and then decrease 
to basal conditions by the morning of metestrus (88). In addi- 
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lion, IGP-I levels decrease by ovariectomy and increase in a 
dose-dependent manner when ovariectomized rats are injected 
with 17B-estradiol, an effect that is blocked by the simultaneous 
administration of progesterone (88). These changes, linked to 
fluctuations of gonadotrophins, suggest that the modulation 
by sex steroids of the levels of IGF-I in the mediobasal hypo- 
thalamus may be related to LHRH regulation. Moreover, these 
changes do not reflect modifications in the local synthesis of 
IGP-T (61,88; see also 89), being probably related to differences 
in the accumulation of IGP-I from extracerebral sources (61). 
CONCLUSION 
M Effects of sex hormones on different neuronal popula- 
tions result in the development of local sex differences in neu- 
ronal number and connectivity. Part of these actions of sex hor- 
mones may be exerted by the modulation of trophic factor sig- 
naling among brain cells. Direct evidence of an interaction of 
sex hormones and trophic factors on neuronal survival and 
differentiation has been obtained in the hypothalamus. Further- 
more, a variety of trophic factors interact with gonadal hormones 
in the brain to regulate neuroendocrine events. Recent findings 
in hypothalamic cultures suggest that the survival and differ- 
entiation of neurons expressing hormone receptors and the re- 
sulting sexual differentiation of brain circuitry and function may 
depend on the coordinated play of hormonal and neurotrophic 
signals acting on neurons and glial cells. 
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